GlaxoSmithKline Czech Republic - EBIT

GlaxoSmithKline CR`s EBIT reached 89.9 CZK mil in 2017. This is 66.2 % more than in the previous year.

$1.99

Buy EBIT data for GlaxoSmithKline Czech Republic.

$19.99

Buy all data for GlaxoSmithKline Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

 
Company Unit 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Amgen Czech Republic ... ... ... ... ...             56.3 35.0 38.9 52.5 44.3    
Bayer Czech Republic ... ... ...                 160 104 128 139 164    
GlaxoSmithKline Czech Republic ... ... ...                 291 216 169 119 127    
Merck Czech Republic ... ...                   65.9 82.5 48.2 52.6 94.7    
Novartis Czech Republic                       56.7 64.0 62.4 97.6 111    
Pfizer Czech Republic ... ...                   303 63.4 170 170 98.2    
Roche Czech Republic ... ... ...                 83.1 69.0 183 134 81.5   ...
Sanofi-Aventis Czech Republic ... ... ... ...               82.9 71.4 89.3 9.99 89.5    
Servier Czech Republic ... ... ... ... ... ... ... ... ... ... ... ... 17.4 18.1 18.3 20.4    
Walmark ... ... ...                 252 57.0 34.1 105 -328